(HealthDay News) — The recall of the commonly prescribed blood pressure drug losartan has been expanded once again to include an additional 5 lots.
The drug, made by Torrent Pharmaceuticals, has been recalled because some lots are contaminated with the cancer-causing chemical N-methylnitrosobutyric acid, according to a company press release.
The drugs added to the recall include lots of Losartan Potassium Tablets, USP, and Losartan Potassium/Hydrochlorothiazide Tablets, USP, all of which have amounts of the contaminant that exceed FDA-recommended levels.
Continue Reading
This recall is the fifth for losartan that Torrent has announced this year.
Enjoying our content?
Thanks for visiting Renal & Urology News. We hope you’re enjoying the latest clinical news, full-length features, case studies, and more.
You’ve viewed {{metering-count}} of {{metering-total}} articles this month. If you wish to read unlimited content, please log in or register below. Registration is free.
{{login-button}} {{register-button}}
Log in to continue reading this article.
Don’t miss out on today’s top content on Renal & Urology News. Register for free and gain unlimited access to:
- Clinical News, with personalized daily picks for you
- Case Studies
- Conference Coverage
- Full-Length Features
- Drug Monographs
- And More
{{login-button}} {{register-button}}
Want to read more?
Please login or register first to view this content.